NEURONETICS INC (STIM) Stock News

USA - NASDAQ:STIM - US64131A1051 - Common Stock

2.52 USD

-0.22 (-8.03%)

Last: 11/6/2025, 8:15:26 PM

2.52 USD

0 (0%)

After Hours: 11/6/2025, 8:15:26 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

STIM Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill - Mentions: CYD HTZ DENN NSP ...

News Image

Tuesday's pre-market session: top gainers and losers

3 days ago - By: Chartmill

News Image

NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss

3 days ago - By: Zacks Investment Research - Mentions: SINT

Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates

3 days ago - By: Neuronetics

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

3 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

7 days ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

8 days ago - By: Neuronetics

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

8 days ago - By: Neuronetics

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

17 days ago - By: Neuronetics

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

2 months ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

2 months ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

3 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: TNDM

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Neuronetics

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

3 months ago - By: Neuronetics

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

3 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

3 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

4 months ago - By: Neuronetics

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

4 months ago - By: Neuronetics

Neuronetics Appoints New Chief Financial Officer

4 months ago - By: Yahoo Finance

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

5 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Neuronetics

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

5 months ago - By: Neuronetics

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

5 months ago - By: Neuronetics

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

6 months ago - By: Neuronetics

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

6 months ago - By: Neuronetics

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

6 months ago - By: Zacks Investment Research - Mentions: GMED

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Neuronetics

Neuronetics Reports First Quarter 2025 Financial and Operating Results

6 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Why Neuronetics, Inc. (STIM) is Surging in 2025

7 months ago - By: Neuronetics

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

7 months ago - By: Neuronetics

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

7 months ago - By: Neuronetics

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

7 months ago - By: Neuronetics

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

8 months ago - By: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results